The Quantellect read.As of Nov 19, 2026, 17 active firms cover Astera Labs, Inc: 11 rate it Buy or better, 6 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. The target range is very wide, $153.00 to $500.00 (about 3.3x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $348.35 sits 61% above the current $216.03. The rating mix has stayed broadly stable, with Buy-side ratings easing from 13 to 11 over recent months. On the fundamentals, the Street sees revenue growth near 81% this year and 42% next, consensus EPS building from about $1.67 next quarter toward $7.15 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS17 active firms
Buy
Strong Buy00%
Buy1165%
Neutral635%
Sell00%
Strong Sell00%
Based on 17 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$348.35
+61.3% upside
Average target across 17 active firms as of Nov 19, 2026 vs $216.03 current
Highest Target$500.00
Average Target$348.35
Lowest Target$153.00
Detailed analyst forecasts for ALAB
Showing 1–18 of 18 named analysts shown · 17 active firms in the rating projection
As of Nov 19, 2026, 11 of 17 active firms rate ALAB a Buy (6 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
ALAB EPS & revenue forecast
EPS · NEXT QUARTER
$1.67
Range $1.55 – $1.97 · 20 analysts · +174% YoY
Next period, 20 analysts expect Astera Labs, Inc. to earn $1.67 a share (range $1.55 – $1.97), versus $0.61 a year earlier. Full-year consensus is $4.38, growing to $7.15 the year after.
REVENUE · NEXT QUARTER
$776.5M
Range $746.0M – $824.0M · 20 analysts · +78% YoY
Revenue is expected to reach $776.5M (range $746.0M – $824.0M), +78.0% year-over-year. Full-year consensus is $2.0B, rising to $3.4B next year.
Top analysts covering Astera Labs, Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ALAB.
#1
Tore Svanberg
Stifel · Rank #37
Buy
$370.00+71.3% to target
Overall win rate
51%
+ Follow
#2
Ananda Baruah
Loop Capital · Rank #139
Buy
$250.00+15.7% to target
Overall win rate
50%
+ Follow
#3
N. Quinn Bolton
Needham · Rank #173
Buy
$425.00+96.7% to target
Overall win rate
39%
+ Follow
#4
Suji Desilva
Roth Capital · Rank #219
Buy
$350.00+62.0% to target
Overall win rate
30%
+ Follow
#5
Richard Shannon
Craig-Hallum · Rank #230
Buy
$275.00+27.3% to target
Overall win rate
37%
+ Follow
ALAB stock forecast FAQ
What is ALAB's average 12-month price target?+
The 17 active firms with a live target average $348.35 for Astera Labs, Inc. over the next 12 months, ranging from a $500.00 high to a $153.00 low, as of Nov 19, 2026.
Is ALAB stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 17 active firms as of Nov 19, 2026, 11 rate it Buy or Strong Buy, 6 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for ALAB?+
The Street-high target is $500.00 (RBC Capital), and the Street-low is $153.00 (Rothschild & Co). The average of all 17 active-firm targets is $348.35.
How many active Wall Street firms cover ALAB?+
17 active firms have a recognized rating on Astera Labs, Inc. as of Nov 19, 2026, and 17 active firms carry a live 12-month price target.
Who is the most accurate analyst covering ALAB?+
Among analysts who currently cover ALAB, Tore Svanberg of Stifel has the strongest overall Quantellect track record (Rank #37). Their current call is Buy with a $370.00 target.
What is Astera Labs, Inc.'s projected EPS for next quarter?+
The consensus estimate is $1.67 per share (range $1.55 – $1.97) across 20 analysts. Full-year EPS is projected at $4.38, rising to $7.15 the following year.
How much revenue is Astera Labs, Inc. expected to report next quarter?+
Consensus revenue is $776.5M (range $746.0M – $824.0M). Full-year revenue is projected at $2.0B, growing to $3.4B next year.
Have analysts been upgrading or downgrading ALAB lately?+
As of Nov 19, 2026, 11 of 17 active firms rate ALAB a Buy (6 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ALAB calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.